14-08-2020
The absence of universal COVID-19 testing in the U.S. makes it impossible to establish prevalence and mortality rates of SARS-CoV-2 infection in various geographic locations and in the nation as a whole. Studies of prevalence have used select subpopulations or nonrandom sampling, both of which have limitations regarding generalizability.
Fonte: https://www.jwatch.org/
